Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB

Fig. 1

Expression of GPNMB in human malignant mesothelioma tissues. A TCGA analysis in 85 MPM patients for mRNA levels of Gpnmb, CD44 and IL-33 genes, and B survival of patients classified according to high/low expression of the GPNMB and CD44 genes. P value by log-rank test. C Plasmatic levels of soluble GPNMB measured by ELISA in 72 patients with pathologically confirmed diagnosis of MPM and in 86 healthy donors. Statistical analysis Unpaired t-test (< 0.0001). D Representative images of immunohistochemistry of GPNMB and E of CD206 in two distinct cases of human MPM. F heat map quantification in 28 MPM patients. G RNAscope experiment in two distinct cases of human MPM: single staining of Gpnmb RNA (purple) or CD68 (brown); double staining (H) is shown for each corresponding sample

Back to article page